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Abstract
Background: H2O2 produced by vaginal lactobacilli is believed to protect against infection, and H2O2-producing 
lactobacilli inactivate pathogens in vitro in protein-free salt solution. However, cervicovaginal fluid (CVF) and semen 
have significant H2O2-blocking activity.
Methods: We measured the H2O2 concentration of CVF and the H2O2-blocking activity of CVF and semen using 
fluorescence and in vitro bacterial-exposure experiments.
Results: The mean H2O2 measured in fully aerobic CVF was 23 ± 5 μM; however, 50 μM H2O2 in salt solution showed no 
in vitro inactivation of HSV-2, Neisseria gonorrhoeae, Hemophilus ducreyii, or any of six BV-associated bacteria. CVF 
reduced 1 mM added H2O2 to an undetectable level, while semen reduced 10 mM added H2O2 to undetectable. 
Moreover, the addition of just 1% CVF supernatant abolished in vitro pathogen-inactivation by H2O2-producing 
lactobacilli.
Conclusions: Given the H2O2-blocking activity of CVF and semen, it is implausible that H2O2-production by vaginal 
lactobacilli is a significant mechanism of protection in vivo.
Background
The health of the female genital tract depends signifi-
cantly upon the composition of the vaginal microflora.
Bacterial vaginosis (BV) is a common microfloral distur-
bance: the lactobacilli that dominate a healthy vaginal
microflora are replaced by a high-density, polymicrobial
m i x  o f  o t h e r  b a c t e r i a  [ 1 , 2 ] .  B V  i s  a s s o c i a t e d  w i t h
increased rates of many different genital tract infections,
suggesting that vaginal lactobacilli provide broad-spec-
trum protection against pathogens.
Hydrogen peroxide is a broad-spectrum disinfectant,
and cervicovaginal fluid (CVF) contains myeloperoxidase
(MPO) that enhances pathogen-inactivation by H2O2
[3,4]. Epidemiological studies suggest that women with
H2O2-producing lactobacilli are less likely to be infected
with HIV-1, HSV-2, Trichomonas vaginalis, Gardnerella
vaginalis, and gram-negative anaerobes associated with
BV [5-7]. Several studies have reported that BV and
H2O2-producing lactobacilli are strongly negatively asso-
ciated: women with BV are between three and twelve
times less likely to have H2O2-producing lactobacilli than
women without BV [8-11].
Hydrogen peroxide-producing lactobacilli have also
been shown to inactivate HIV-1 virions, and BV-associ-
ated bacteria when tested in protein-free salt solutions,
giving support to the hypothesis that H2O2-production
by vaginal lactobacilli is protective [12,13]. However, CVF
and semen contain proteins, glycoproteins, polysaccha-
rides, lipids, and other molecules with the potential to
react with and inactivate H2O2. Additionally, the vagina is
hypoxic most of the time, though the concentration of
oxygen in the vagina increases following the insertion of a
contraceptive diaphragm, during sexual arousal, and pre-
sumably during sexual intercourse [14-16]. Lactobacilli
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require oxygen to produce hydrogen peroxide: H2O2 con-
centration is undetectable during anaerobic culture,
reaches 29-450 μM during aerobic culture, and 1.0-1.8
mM with vigorous aeration [17-19].
The primary aim of this study was to measure the H2O2
concentration of CVF from women with H2O2-producing
lactobacilli microflora, and the H2O2-blocking activities
of CVF and semen, to assess the likelihood that H2O2 pro-
duced by vaginal lactobacilli provides significant protec-
tion  in vivo. Additionally, we tested whether H2O2 in
simple salt solution at somewhat more than the concen-
tration found in our CVF samples could inactivate vaginal
pathogens, and whether CVF has the ability to block
pathogen-inactivation by H2O2-producing lactobacilli.
Methods
All materials and reagents were supplied by Sigma-
Aldrich Inc. (St. Louis MO) unless otherwise specified; all
microorganisms were supplied by the American Type
Culture Collection (Manassas VA).
Cervico-vaginal fluid and semen donors
The study was carried out at the Johns Hopkins Univer-
sity Homewood campus; participants were recruited pri-
marily from among students and staff at the university.
Our research conforms to the requirements of the Decla-
ration of Helsinki, and the relevant federal and state laws;
each participant gave written informed consent under a
protocol approved by the Homewood Institutional
Review Board on the Use of Human Subjects at Johns
Hopkins University. Participants were required to be
between 18 and 45 years old, and in good general health;
female participants were at least three days past the most
recent menstruation or unprotected penile-vaginal inter-
course, at least three weeks past the most recent use of
vaginal or systemic antimicrobials, and free from vaginal
symptoms (discharge, odour, itching, or pain). Results
from samples donated by six male and twenty-two female
participants are reported here; the group comprised
roughly equal numbers of non-Hispanic whites, blacks,
and Asians, aged between 18 and 44 years old (mean age
26 ± 5 years).
Collection of cervicovaginal fluid and semen samples
The non-absorbent disposable Instead®  menstrual cup
(Instead Inc., La Jolla CA) was used to sample non-men-
strual CVF. Unlike the more common collection methods
of lavage, tampon, swab, or filter paper, the Instead® cup
collects a relatively large sample of CVF (a mix of cervical
mucus, other secretions, and transudate) from a large
area of the vagina without the use a speculum or dilution
of the sample [20-22]. CVF adheres to the rim and both
sides of the dome of the Instead® cup, and is removed
from the device by centrifugation.
The Instead® cup was vaginally inserted, removed, and
placed in a conical tube that was immediately transferred
to a glove-box mimicking the hypoxia that generally pre-
vails in the vagina: partial pressure of oxygen in the glove-
box was 6.0 mm Hg ± 0.7 mm Hg, as measured with an
MI-730 oxygen electrode (Microelectrodes Inc., Bedford
NH), similar to the 4-14 mm Hg reported for the vagina
[23]. Anaerotest®  indicator strips (manufacturer's esti-
mated threshold of sensitivity 7 mm Hg, EMD Chemicals
Inc., Gibbstown NJ) were used to ensure that the glove-
box maintained hypoxic conditions throughout experi-
ments. The tube containing the Instead® was sparged with
nitrogen and sealed. In all cases, the time elapsed
between inserting the Instead® into the vagina, sparging
and sealing the tube in the glove-box was less than one
minute. The sealed tube was removed from the glove-
box, centrifuged for 1 minute at 1000 rpm (500g), and
returned to the glove-box before being opened.
Semen samples were obtained by masturbation, main-
tained aerobically at room temperature, and used within
45 minutes of collection. Neither CVF nor semen samples
were pooled; each experiment was performed several
times (see results for n values) using samples from differ-
ent donors.
Evaluation of the samples
A smear from each sample of CVF was gram-stained and
scored using the Nugent standardized system [24]. Sam-
ples for use in the study were restricted to those with
Nugent scores ≤3 (indicating healthy vaginal microflora)
and absence of vaginal leucorrhea (mean polymorphonu-
clear leukocyte per high powered field [PMNL/hpf] <10)
[25]. A total of twenty-four female participants donated
CVF; two samples were discarded due to Nugent scores
>3, and no samples were excluded due to leucorrhea
(mean PMNL/hpf of the included samples was 2.1). The
low rate of discarded samples is consistent with the par-
ticipant exclusion criteria (i.e., presence of any vaginal
symptoms), and the study population's low-risk composi-
tion (generally young, affluent, with a high rate of con-
dom use, and low rates of smoking, vaginal cleansing, and
sexually transmitted infections).
H2O2-production in each CVF sample was assessed by
growth on TMB-plus agar [26]; all samples met the crite-
ria for H2O2-producing microflora [27], consistent with
the characteristics of the study population [28,29]. An ali-
quot from each sample of semen was viability-stained,
and the number of live sperm, dead sperm, and leuko-
cytes present were scored [30]. All semen samples col-
lected met WHO criteria for normal quality [31].O'Hanlon et al. BMC Infectious Diseases 2010, 10:120
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Measuring hydrogen peroxide concentration in 
cervicovaginal fluid
Amplex Red® (Invitrogen, Eugene OR) substrate in combi-
nation with horseradish peroxidase is a sensitive fluores-
cence assay for H2O2 [32]. Following the manufacturer's
protocol, the assay reactions contained 50 μM Amplex
Red®, 1 U/mL horseradish peroxidase, and 100 μL of CVF
or semen in a 200 uL final reaction volume; however, the
concentration of the reaction salt solution was increased
from 50 mM to 250 mM to maintain an optimal reaction
pH in the presence of CVF. Control experiments showed
the change in salt solution concentration did not interfere
with the ability of the assay to detect and quantify H2O2
(data not shown). The assay was carried out hypoxically
or aerobically as indicated for the individual experiments.
Control experiments showed that deoxygenating with
nitrogen and incubating hypoxically did not interfere
with the sensitivity or accuracy of the assay (data not
shown).
Measuring hydrogen peroxide-blocking activity of 
cervicovaginal fluid and semen
The oxidant-blocking activity in a sample differs with
respect to different oxidant species [33,34]; we therefore
tested the ability of CVF and semen to block exogenous
H2O2. Aliquots of CVF or semen were diluted with an
equal volume of 250 mM Na2HPO4 containing H2O2 at
concentrations between 20 μM and 2 M, giving final
H2O2 concentrations between 10 μM and 1 M. These ali-
quots were stirred for five seconds, and H2O2 concentra-
tion was measured aerobically using the Amplex Red®
assay.
Measuring effect of aerobic exposure on hydrogen 
peroxide in cervicovaginal fluid
To estimate the amount of H2O2 produced in the gener-
ally hypoxic environment of the vagina, the H2O2 of CVF
was measured immediately after sample collection and
transfer to the hypoxic glove-box (i.e., after the approxi-
mately one minute aerobic exposure necessitated by the
collection method). Some CVF samples were then main-
tained hypoxically at 37°C for one and a half hours, with
an aliquot withdrawn every fifteen minutes and assayed
hypoxically for H2O2 content.
To estimate the amount of H2O2 produced during peri-
ods of increased vaginal oxygen (as during sexual inter-
course, when sexually transmitted pathogens might be
introduced), CVF samples were first hypoxically equili-
brated at 37°C for four hours, then exposed to air for one
minute, fifteen minutes, or four hours and assayed for
H2O2 content.
Measuring effect of CVF supernatant on pathogen-
inactivation by H2O2-producing lactobacilli
The production of H2O2  by  Lactobacillus crispatus
ATCC® 33820™ was confirmed by growth on TMB-plus
agar. We replicated the protocol used by Klebanoff et al
[35] to test in vitro pathogen-inactivation by H2O2-pro-
ducing lactobacilli: L. crispatus was grown anaerobically
in Difco™ Lactobacilli MRS broth (Becton, Dickinson and
Co., Sparks MD) for approximately 24 hours; six hours
before use in an experiment, the lactobacilli were trans-
ferred to peptone-yeast extract broth and grown aerobi-
cally with vigorous agitation. Gardnerella vaginalis
ATCC® 14018™ was grown anaerobically in NYC III broth
for approximately 24 hours; three hours before use in an
experiment, the bacteria were transferred to peptone-
starch-dextrose broth and grown aerobically with vigor-
ous agitation. Prevotella bivia ATCC® 29303™ was grown
anaerobically in chopped meat broth for approximately
24 hours. Immediately before an experiment, the cultures
of all three bacterial species were washed twice in 100
mM Na2SO4, and re-suspended in Na2SO4 containing 100
mM NaCl and 48 mU/mL human MPO. A 250 μL aliquot
of re-suspended G. vaginalis or P. bivia was mixed with
an equal volume of re-suspended L. crispatus.
To avoid conflating endogenous vaginal bacteria with
the cultured L. crispatus, G. vaginalis, and P. bivia used in
these experiments, bacteria-depleted supernatants of
CVF were prepared: each collected sample was diluted
with a half-volume of 0.9% saline, mixed thoroughly, cen-
trifuged at 1000 g for three minutes, and the supernatant
drawn off for immediate use in an experiment [36]. Con-
trol experiments showed this centrifugation reduced bac-
terial concentrations in the diluted CVF from a mean of
5.6 × 107 cfu/mL to a mean of 4.0 × 101 cfu/mL (data not
shown). The CVF supernatant (or an equal volume of
saline as a negative control) was added to the washed and
re-suspended G. vaginalis or P. bivia immediately before
the addition of the L. crispatus.  G. vaginalis mixtures
were incubated aerobically at 37°C for 1 hour, then seri-
ally diluted with 100 mM Na2SO4 and plated onto blood
agar that was incubated aerobically. P. bivia mixtures
were incubated aerobically at 37°C for 30 minutes, then
serially diluted with 0.9% saline containing 0.02% dithio-
threitol, and duplicate-plated onto two sets of brucella
agar plates; one set was incubated aerobically and the
other anaerobically. After approximately 36 hours, plated
colonies were counted: as in Klebanoff's experiments, G.
vaginalis was distinguished from L. crispatus by colony
morphology, growth habit, and presence of haemolysis
on blood agar; P. bivia was distinguished from L. crispa-
tus by colony morphology, growth habit, and the failure
of P. bivia to grow on the aerobically incubated plates.O'Hanlon et al. BMC Infectious Diseases 2010, 10:120
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Measuring pathogen-inactivation by 50 μM exogenous 
hydrogen peroxide
In these experiments, we replaced the H2O2-producing L.
crispatus with exogenous H2O2 at a concentration above
the concentration we measured in CVF samples, and
expanded the list of target pathogens. Mycoplasma homi-
nis  ATCC®  14268™,  Mobiluncus curtsii ATCC®  35241™,
Mobiluncus mulieris ATCC® 35239™,  Peptostreptococcus
anaerobius ATCC® 27337™, Hemophilus ducreyii ATCC®
33940™, G. vaginalis and P. bivia were grown anaerobi-
cally, washed, and re-suspended as described for P. bivia,
above. Neisseria gonorrhoeae ATCC® 19424™ was grown
aerobically in ATCC® medium #814, washed and re-sus-
pended in the same way as P. bivia.
Aliquots of each individual bacterial culture were
mixed with an equal volume of 100 mM Na2SO4 contain-
ing either 100 μM H2O2 with 100 mU/mL MPO, or 100
μM H2O2 without MPO, or plain salt solution as a nega-
tive control. The aliquots were incubated aerobically at
37°C for 1 hour, then serially diluted with 100 mM
Na2SO4 and plated onto blood agar; plates were incu-
bated for approximately 36 hours and colonies counted.
Aliquots of HSV-2 cell-free virus (ATCC®  VR-734™)
were mixed with an equal volume of 100 μM H2O2 and
100 mU/mL MPO, or 100 μM H2O2 without MPO, or
plain 100 mM Na2SO4, and incubated aerobically at 37°C
for 30 minutes. The aliquots were then serially diluted
with DMEM cell-growth medium supplemented with
10% fetal bovine serum (SAFC Biosciences, Lenexa KS)
and plated onto ELVIS HSV-2 indicator cells (Diagnostic
Hybrids, Athens OH), which were incubated, fixed,
stained, and enumerated according to the manufacturer's
instructions.
Statistical analysis
Results are reported as means ± SDs of at least four inde-
pendently repeated experiments. Difference between
three or more means was tested using an ANOVA one-
way analysis of variance; difference between two means
was tested using a two-tailed Student's t test (compari-
sons are paired unless otherwise indicated in the results).
Statistical analysis was performed using Microsoft Excel
PHSTAT.
Results
Hydrogen peroxide in cervicovaginal fluid
Hydrogen peroxide was only detectable after aerobic
exposure: CVF samples (n = 6) incubated hypoxically for
one hour had no detectable H2O2 remaining (Figure 1).
Samples equilibrated hypoxically for four hours produced
H2O2 following even brief exposures to air (Figure 2, open
circles). H2O2 concentration was 15 μM ± 4 μM (n = 4)
after 1 minute of aerobic exposure, and rose to 22 μM ± 4
μM after 15 minutes (n = 4), but H2O2 concentration did
not continue to rise with further aerobic exposure. H2O2
concentration was 23 μM ± 5 μM after 4 hours in air (n =
8), not significantly increased (P = .36) compared to the
concentration after 15 minutes (Figure 2, open circles).
The mean H2O2  content of CVF samples (n = 16)
assayed immediately after sample collection and transfer
to the hypoxic glove-box (i.e., after approximately one
minute of aerobic exposure) was 12 μM ± 5 μM. There
was no significant difference (unpaired comparison, P =
Figure 1 Endogenous H2O2 concentration in cervico-vaginal fluid 
(CVF) measured by Amplex Red® assay, as a function of time for: 
CVF in air, CVF in a hypoxic glove-box, and bacterially-depleted 
CVF in air; all samples were pre-exposed to air (n = 6 for each con-
dition).
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Figure 2 Endogenous H2O2 concentration in CVF samples mea-
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.77) in H2O2 content between this group of CVF samples
assayed immediately after collection, and the samples
assayed after four hours hypoxic incubation followed by
one minute of aerobic exposure (Figure 2, closed circles
versus open circles), supporting our conclusion that 4
hours hypoxia had not affected the samples' ability to
produce H2O2 when exposed to air.
In vitro pathogen-inactivation by 50 μM exogenous 
hydrogen peroxide
Exogenous H2O2 at 50 μM (more than the maximum con-
centration we found in fully aerobically exposed CVF)
had no effect on HSV-2, N. gonorrhoeae, H. ducreyii, or
any of six BV-associated bacteria, when tested under in
vitro conditions designed to maximize H2O2 pathogen-
inactivation (i.e., with addition of MPO and NaCl, in a
protein-free salt solution (Table 1).
Blocking of exogenous hydrogen peroxide by 
cervicovaginal fluid and semen
In all CVF samples tested (n = 8), addition of exogenous
H2O2 to 1 mM produced no significant increase (P = .53)
in the concentration of H2O2 detected (Figure 3, closed
squares); in semen (n = 6), addition of H2O2 to 10 mM
produced no significant increase (P = .72) (Figure 3, open
squares).
Blocking by CVF supernatant of pathogen-inactivation by 
H2O2-producing lactobacilli
Consistent with the report by Klebanoff et al of patho-
gen-inactivation by H2O2-producing lactobacilli, we
Table 1: Viable organisms/mL before and after one hour exposure to 100 mM Na2SO4, 50 μM H2O2, or 50 μM H2O2 with 50 
mU/mL MPO.
Initial infectious 
*units/mL
Infectious *units/mL after 1 hour exposure
100 mM Na2SO4 50 μM H2O2 50 μM H2O2 with 
50 mU/mL MPO
HSV-2 1.0 × 105 1.1 × 105 1.2 × 105 1.2 × 105 NS (P = 0.45)
N. gonorrhoeae 1.5 × 107 1.4 × 107 1.3 × 107 1.4 × 107 NS (P = 0.79)
H. ducreyi 1.4 × 107 1.1 × 107 1.5 × 107 1.4 × 107 NS (P = 0.59)
G. vaginalis 8.2 × 107 8.3 × 107 8.3 × 107 8.5 × 107 NS (P = 0.55)
P. bivia 9.2 × 108 9.0 × 105 8.2 × 105 8.8 × 105 NS (P = 0.28)
M. hominis 7.8 × 107 7.7 × 107 7.6 × 107 7.8 × 107 NS (P = 0.39)
M. curtsii 6.1 × 107 4.8 × 107 4.2 × 107 4.4 × 107 NS (P = 0.22)
M. mulieris 8.5 × 107 3.3 × 107 3.4 × 107 3.4 × 107 NS (P = 0.19)
P. anaerobius 7.4 × 108 4.0 × 106 4.3 × 106 4.4 × 106 NS (P = 0.37)
P values from ANOVA comparison of post-exposure means for all three conditions.
* Colony-forming units/mL for bacteria, infected indicator cells/mL for HSV-2.
Figure 3 H2O2 concentration detected by Amplex Red® assay in 
CVF (n = 8) and semen (n = 6) samples, versus the concentration 
of exogenous H2O2 added to the samples.
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found that G. vaginalis aerobically exposed for 1 hour to
H2O2-producing L. crispatus in a salt solution containing
MPO and NaCl showed complete inactivation; P. bivia
exposed for 30 minutes to L. crispatus in salt solution
containing MPO and NaCl also showed complete inacti-
vation (Figure 4). However, the addition of CVF superna-
tant to a final CVF concentration of just 1% w/v abolished
all inactivation; there was no significant reduction (paired
comparisons, individual p values given in Table 1) in cfu/
mL of G. vaginalis or P. bivia exposed for one hour to
MPO, NaCl, 1% CVF, and H2O2-producing L. crispatus,
compared to controls exposed to MPO, NaCl, 1% CVF ,
and no L. crispatus. As little as 0.1% CVF resulted in sig-
nificant reduction in inactivation of G. vaginalis and P.
bivia (P = 0.05).
Discussion
Hydrogen peroxide production by vaginal lactobacilli has
been widely emphasized as a mechanism of protection
against genital tract pathogens. This view is based on epi-
demiological association, plausibility of mechanism, and
in vitro studies of pathogen inactivation by H2O2-produc-
ing lactobacilli in protein-free salt solution, but CVF and
semen contain proteins, glycoproteins, polysaccharides,
lipids, and other molecules with H2O2-blocking activities.
Indeed, a previous investigator noted that the toxicity of
an  in vitro H2O2-peroxidase-halide system against
Escherichia coli was compromised by even trace amounts
of protein [37]. Additionally, previous in vitro experi-
ments were done under aerobic conditions that maximize
H2O2-production, whereas the vagina is generally
hypoxic.
Our hypoxic glove-box mimicked the hypoxic condi-
tion of the vagina. The H2O2 content of CVF samples
decreased during incubation in the glove-box and
became undetectable (<1 μM) within one hour, suggest-
ing that H2O2 would generally be undetectable in vivo.
The H2O2 of CVF samples collected with brief (~1 min-
ute) aerobic exposure and assayed immediately under
hypoxic conditions was not significantly different from
that measured in samples equilibrated under hypoxic
conditions (i.e., to the point where they contained no
detectable H2O2) and then exposed to air for one minute.
We conclude that the H2O2 detected in the CVF samples
immediately following collection is attributable to the
brief aerobic exposure.
The oxygen concentration in the vagina increases sub-
stantially during sexual intercourse. However, the mean
H2O2 content in CVF samples after four hours of full
exposure to air was still only 23 ± 5 μM, one hundred
times lower than maximal aerobic in vitro production (~2
mM). We attribute this lower H2O2 content to the H2O2-
blocking activity of CVF: even if H2O2-production
reached millimolar concentrations, CVF had sufficient
H2O2-blocking activity to leave only micromolar amounts
available to the assay reaction (and presumably to patho-
gen-inactivating reactions in vivo). This interpretation is
supported by our finding that CVF samples spiked with
millimolar concentrations of exogenous H2O2 still only
contained micromolar concentrations of detectable
H2O2. It may seem surprising, given the copious H2O2-
blocking activity of CVF, that any H2O2 could be detected
at all. We attribute this to the continuing production of
H2O2 by the lactobacilli in our CVF samples during and
after aerobic exposure: when the Amplex Red® substrate
was added to the sample, it competed with the endoge-
nous H2O2-blocking activity for the newly forming H2O2.
Our hypothesis is supported by our finding that the H2O2
concentration decreased during aerobic incubation of
bacterially-depleted CVF supernatant (n = 6), becoming
undetectable after 45 minutes (Figure 1).
H2O2 at 50 μM (more than the maximum concentration
we found in CVF) produced no inactivation of HSV-2, N.
gonorrhoeae, H. ducreyii, or six major BV-associated bac-
teria, even in protein-free salt solution supplemented
with MPO to enhance H2O2 toxicity. (P. bivia and  P.
anaerobius did show significant loss of viability (P = 0.01)
irrespective of whether H2O2 was present or not, attribut-
a b l e  t o  t h e  e f f e c t  o f  a e r o b i c  e x p o s u r e  o n  t h e s e  s t r i c t
anaerobes.) Additionally, the in vitro inactivation of G.
vaginalis and P. bivia by H2O2-producing L. crispatus was
completely abolished by the addition of only 1% CVF.
Our study has the following limitations: firstly, the con-
centration of H2O2 may be substantially higher in the
immediate vicinity of H2O2-producing lactobacilli, and
Figure 4 Effect of CVF on the in vitro inactivation of G. vaginalis 
and P. bivia by H2O2-producing L. crispatus. Surviving fraction of or-
ganisms is plotted against concentration of CVF in the exposure solu-
tion.
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u n d e r e s t i m a t e d  b y  o u r  m e a s u r e m e n t s  i n  b u l k  C V F .  A
high local concentration of H2O2 might inactivate patho-
gens in close proximity to lactobacilli, even though the
dispersed H2O2 concentration had no pathogen-inacti-
vating activity (Table 1). Against this hypothesis is the
fact that co-culture with H2O2-producing lactobacilli in
the presence of CVF supernatant failed to inactivate both
G. vaginalis and P. bivia, Second, the bacteria used in
these experiments are established laboratory strains; pri-
mary isolates might be more sensitive to H2O2, although
it is unclear how laboratory passage would provide selec-
tive pressure toward greater H2O2 resistance.
Conclusions
Given the H2O2-blocking activity of CVF and semen, we
conclude that H2O2-production by vaginal lactobacilli is
implausible as a mechanism of direct protection against
genital tract pathogens generally, and sexually-transmit-
ted pathogens in particular. There remains the strong
inverse association between H2O2-producing lactobacilli
and BV. We hypothesize that lactobacilli strains that pro-
duce H2O2 may also produce more of other microbicidal
factors such as lactic acid or bacteriocins, or alternatively,
that H2O2-producing lactobacilli may be more suscepti-
ble to inhibitory factors elaborated by BV-associated
organisms. We are currently investigating these possibili-
ties.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
DEOH designed the study, collected data, analyzed the data, and prepared the
manuscript. BL designed the study and collected data. TM participated in data
analysis and the preparation of the manuscript. RC participated in data analysis
and the preparation of the manuscript. All of the authors read and approved
the final manuscript.
Acknowledgements
The work was supported by NIH grants AI45967, AI60598, and AI66726.
Author Details
1Mucosal Protection Laboratory, Thomas C. Jenkins Department of Biophysics, 
Johns Hopkins University, Baltimore, MD 21218, USA and 2ReProtect, Inc., 
Baltimore, MD 21286, USA
References
1. Livengood CH: Bacterial vaginosis: an overview for 2009.  Rev Obstet 
Gynecol 2009, 2:28-37.
2. Allsworth JE, Peipert JF: Prevalence of bacterial vaginosis: 2001-2004 
National Health and Nutrition Examination Survey data.  Obstet Gynecol 
2007, 109:114-20.
3. Klebanoff SJ, Hillier SL, Eschenbach DA, Waltersdorph AM: Control of the 
microbial flora of the vagina by H2O2-generating lactobacilli.  JID 1991, 
164:94-100.
4. Klebanoff SJ: MPO: friend and foe.  J Leukoc Biol 2005, 77:598-625.
5. Atashili J, Poole C, Ndumbe PM, Adimora AA, Smith JS: Bacterial vaginosis 
and HIV acquisition: a meta-analysis of published studies.  AIDS 2008, 
22:1493-501.
6. Baeten J, Hassan W, Chohan V, Richardson B, Mandaliya K, Ndinya-Achola 
J, Jaoko W, McClelland RS: Prospective study of correlates of vaginal 
Lactobacillus colonization among high-risk HIV-1 seronegative 
women.  Sex Transm Infect 2009 in press.
7. Demba E, Morison L, Loeff MS van der, et al.: Bacterial vaginosis, vaginal 
flora patterns and vaginal hygiene practices in patients presenting 
with vaginal discharge syndrome in The Gambia, West Africa.  BMC 
Infect Dis 2005, 5:12.
8. Eschenbach DA, Davick PR, Williams BL, et al.: Prevalence of hydrogen 
peroxide-producing Lactobacillus species in normal women and 
women with bacterial vaginosis.  J Clin Microbiol 1989, 27:251-6.
9. Al-Mushrif S, Jones BM: A study of the prevalence of hydrogen peroxide 
generating Lactobacilli in bacterial vaginosis: the determination of 
H2O2 concentrations generated in vitro by isolated strains and the 
levels found in vaginal secretions of women with and without 
infection.  J Obstet Gynaecol 1998, 18:63-7.
10. Mijac VD, Dukic SV, Opavski NZ, Dukic MK, Ranin LT: Hydrogen peroxide 
producing lactobacilli in women with vaginal infections.  Eur J Obstet 
Gynecol Reprod Biol 2006, 129:69-76.
11. Cherpes TL, Hillier SL, Meyn LA, Busch JL, Krohn MA: A delicate balance: 
risk factors for acquisition of bacterial vaginosis include sexual activity, 
absence of hydrogen peroxide-producing lactobacilli, black race, and 
positive Herpes Simplex Virus Type 2 serology.  Sex Trans Dis 2008, 
35:78-83.
12. Klebanoff SJ, Coombs RW: Viricidal effect of Lactobacillus acidophilus on 
Human Immunodeficiency Virus type 1: possible role in heterosexual 
transmission.  J Exp Med 1991, 174:289-92.
13. Klebanoff SJ, Hillier SL, Eschenbach DA, Waltersdorph AM: Control of the 
microbial flora of the vagina by H2O2-generating lactobacilli.  JID 1991, 
164:94-100.
14. Sommer F, Caspers HP, Esders K, Klotz T, Engelman U: Measurement of 
vaginal and minor labial oxygen tension for the evaluation of female 
sexual function.  J Urol 2001, 166:2324-25.
15. Wagner G, Levin RJ, Bohr L: Diaphragm insertion increases human 
vaginal oxygen tension.  Am J Obstet Gynecol 1988, 158:1040-43.
16. Wagner G, Levin R: Oxygen tension of the vaginal surface during sexual 
stimulation in the human.  Fertil Steril 1978, 30:50.
17. Whittenbury R: Hydrogen peroxide formation and catalase activity in 
the lactic acid bacteria.  J Gen Microbiol 1964, 35:13-26.
18. Aslim B, Kilic E: Some probiotic properties of vaginal lactobacilli isolated 
from healthy women.  Jpn J Infect Dis 2006, 59:249-53.
19. Strus M, Brzychczy-Wloch M, Gosiewski T, Kochan P, Heczko PB: The in 
vitro effect of hydrogen peroxide on vaginal microbial communities.  
FEMS Immunol Med Microbiol 2006, 48:56-63.
20. Shaw JL, Smith CR, Diamandis EP: Proteomic analysis of human cervico-
vaginal fluid.  J Proteome Res 2007, 6:2859-65.
21. Klein LL, Jonscher KR, Heerwagen MJ, Gibbs RS, McManaman JL: Shotgun 
proteomic analysis of cervico-vaginal fluid from women in late 
pregnancy.  Reprod Sci 2008, 15:263-73.
22. Boskey ER, Moench TR, Hees PS, Cone RA: A self-sampling method to 
obtain large volumes of undiluted cervicovaginal mucus.  Sex Trans Dis 
2003, 30:107-9.
23. Hill DR, Brunner ME, Schmitz DC, Davis CC, Flood JA, Schlievert PM, Wang-
Weigand SZ, Osborn TW: In vivo assessment of human vaginal oxygen 
and carbon dioxide levels during and post menses.  J Appl Physiol 2005, 
99:1582-91.
24. Nugent RP, Krohn MA, Hillier SL: Reliability of diagnosing bacterial 
vaginosis is improved by a standardized method of Gram stain 
interpretation.  J Clin Microbiol 1991, 29:297-301.
25. Lusk MJ, Konecny P: Cervicitis: a review.  Curr Opin Infect Dis 2008, 
21:49-55.
26. Rabe LK, Hillier SL: Optimization of media for detection of hydrogen 
peroxide production by Lactobacillus species.  J Clin Microbiol 2003, 
41:3260-4.
27. Martin HL, Richardson BA, Nyange PM, et al.: Vaginal lactobacilli, 
microbial flora, and risk of Human Immunodeficiency Virus Type 1 and 
sexually transmitted disease acquisition.  JID 1999, 180:1863-1868.
Received: 13 December 2009 Accepted: 19 May 2010 
Published: 19 May 2010
This article is available from: http://www.biomedcentral.com/1471-2334/10/120 © 2010 O'Hanlon et al; licensee BioMed Central Ltd.  This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. BMC Infectious Diseases 2010, 10:120O'Hanlon et al. BMC Infectious Diseases 2010, 10:120
http://www.biomedcentral.com/1471-2334/10/120
Page 8 of 8
28. Antonio MA, Hawes SE, Hillier SL: The identification of vaginal 
Lactobacillus species and the demographic and microbiologic 
characteristics of women colonized by these species.  J Infect Dis 1999, 
180:1950-6.
29. Beigi RH, Wiesenfeld HC, Hillier SL, Straw T, Krohn MA: Factors associated 
with absence of H2O2-producing Lactobacillus among women with 
bacterial vaginosis.  J Infect Dis 2005, 191:924-9.
30. Eliasson R, Treich L: Supervital staining of human spermatozoa.  Fertil 
Steril 1971, 22:134-7.
31. WHO Laboratory manual for the examination of Human semen and Sperm-
Cervical mucus interaction 3rd edition. Cambridge University Press; 1992. 
32. Zhou M, Diwu Z, Panchuk-Voloshina N, Haugland RP: A stable 
nonfluorescent derivative of resorufin for the fluorometric 
determination of trace hydrogen peroxide: applications in detecting 
the activity of phagocyte NADPH oxidase and other oxidases.  Anal 
Biochem 1997, 253:162-8.
33. Huang D, Ou B, Prior RL: The chemistry behind antioxidant capacity 
assays.  J Agric Food Chem 2005, 53:1841-56.
34. Magalhães LM, Segundo MA, Reis S, Lima JL: Methodological aspects 
about in vitro evaluation of antioxidant properties.  Anal Chim Acta 
2008, 613:1-19.
35. Klebanoff SJ, Hillier SL, Eschenbach DA, Waltersdorph AM: Control of the 
microbial flora of the vagina by H2O2-generating lactobacilli.  JID 1991, 
164:94-100.
36. Dimitonova SP, Danova ST, Serkedjieva JP, Bakalov BV: Antimicrobial 
activity and protective properties of vaginal lactobacilli from healthy 
Bulgarian women.  Anaerobe 2007, 13:178-84.
37. Klebanoff SJ, Waltersdorph AM, Rosen H: Antimicrobial activity of MPO.  
Methods Enzymol 1984, 105:399-403.
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1471-2334/10/120/prepub
doi: 10.1186/1471-2334-10-120
Cite this article as: O'Hanlon et al., Cervicovaginal fluid and semen block the 
microbicidal activity of hydrogen peroxide produced by vaginal lactobacilli 
BMC Infectious Diseases 2010, 10:120